matter news
MATTER announces new series on AI in Commercial Pharma
Four-part series will run in Fall 2026 with support from EVERSANA INTOUCH.
Pharma brand teams are presented with a growing array of AI solutions across brand strategy, field engagement, market access and patient identification. But relatively few leaders are confident about how to prioritize use cases and determine which solutions will create real value and reshape their organizations to maxim…